HPV 16+ Recurrent or Metastatic Cancer
2 clinical trials · Condition
◉ Watch HPV 16+ Recurrent or Metastatic Cancer
| Record | Firm | Date |
|---|---|---|
| Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors (NCT07081984) | Therorna | 2025-11-11 |
| Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers (NCT04713046) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
Track HPV 16+ Recurrent or Metastatic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.